(untitled)
Radial is acquiring the non-clinical assets of a leading interventional psychiatry group with 20 brain medicine clinics. These clinics offer cutting-edge brain medicine treatments, including Spravato and TMS.
Fierce Healthcare - providers
Overdue Last read · next check
Last read 6 hours ago, longer than this feed's 1 hour schedule.
Latest posts
(untitled)
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here at the end of each week.
(untitled)
GLP-1s are disrupting a healthcare system built around treating obesity-related complications, forcing providers, insurers and investors to rethink where future revenue and growth will come from, according to a new report from Wells Fargo.
(untitled)
Carrum’s Centers of Excellence network for specialty care will be embedded directly into Included Health’s Alternative Health Plan to help connect members to high-quality specialty care with more predictable costs.
(untitled)
Hospitals' operating margins remain inconsistent across the industry, with rising uncompensated care burden and non-labor expenses increasingly weighing down performance, according to June operating data.
(untitled)
Tarek Salaway's complaint contests the academic system's publicly shared account of his conduct and seeks $15.5 million in damages.
(untitled)
As rural healthcare faces access challenges, Hopscotch focuses on a smooth and attentive patient experience while augmenting clinicians with technology.
(untitled)
The country's largest nonprofit health system outlined a 10.9% year-over-year increase in operating revenues for the quarter ended June 30.
(untitled)
The administration is seeking voluntary commitments from hospitals to serve less processed foods in line with recently updated dietary guidelines, which officials said will boost chronic disease prevention and general long-term wellness.
(untitled)
Female-specific oncology is expected to grow from about $65 billion today to $75 billion, and then to $100 billion to $110 billion in 2030. This growth will be derived from areas such as therapeutics, devices and diagnostics and care delivery.